Disclosure statement
No potential conflict of interest was reported by the author(s).
Additional information
Funding
This work was supported in part by the University of Iowa/Mayo Clinic Lymphoma SPORE CA97274.
Leukemia & Lymphoma
Volume 61, 2020 - Issue 11
Letters to the Editor
Low-dose vemurafenib monotherapy in BRAFV600E-mutated Erdheim-Chester disease
Gordon J. Ruana Division of Hematology, Mayo Clinic, Rochester, MN, USA
https://orcid.org/0000-0002-6969-9169View further author information
https://orcid.org/0000-0002-6969-9169View further author information, , , Caleb Scheckela Division of Hematology, Mayo Clinic, Rochester, MN, USAhttps://orcid.org/0000-0002-7248-2219View further author information
https://orcid.org/0000-0002-7248-2219View further author information, , , W. Oliver Tobinc Department of Neurology, Mayo Clinic, Rochester, MN, USAhttps://orcid.org/0000-0002-8141-2394View further author information
https://orcid.org/0000-0002-8141-2394View further author information, , , , , , & show all![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})